Login to Your Account



Sanofi in legal tussle with Filipino authorities over Dengvaxia controversy

By David Ho
Staff Writer

Wednesday, February 14, 2018

HONG KONG – Sanofi Pasteur Ltd. is taking a stand for itself amid a controversy that has quickly become a legal battle. The Public Attorney's Office of the Philippines (PAO) is taking legal action against Sanofi over the controversy surrounding the dengue vaccine Dengvaxia. And, the Filipino government agency recently filed a lawsuit against the French pharma company to demand compensation of up to PHP4.2 million (US$81,164) for the parents of Anjielica Pestilos, a 10-year-old girl the agency claims had died as a result of receiving its dengue vaccine.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription